STAT3 and cancer: In vitro, hesperidin affected PD-L1 expression in HN6 cells and HN15 cells by reducing the phosphorylation of STAT1 and STAT3, thereby inhibiting cancer cell survival and avoiding evasion of antitumor immunity.